A pregnant woman seeking a medication abortion in Nebraska would be required under a new bill to attend an in-person ...
Judge Matthew Kacsmaryk, a Trump appointee, allowed three states to go forward with a lawsuit that seeks to change how ...
Since the U.S. Supreme Court’s decision in 2022 to allow states to regulate abortion access, support for expanded access to ...
After hitting a regulatory roadblock in 2022, Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to ...
Since the U.S. Supreme Court’s decision in 2022 to allow states to regulate abortion, support for expanded access to abortion ...
The federal judge who paved a path for abortion drug clearance to reach the Supreme Court has allowed red states to revive ...
The three states argue that the FDA's approval of mifepristone for use up to 10 weeks of pregnancy, along with its availability via telemedicine and mail, has contributed to what they view as a public ...
Idaho, Kansas and Missouri want the federal Food and Drug Administration to prohibit telehealth prescriptions for ...
A judge in Texas ruled Thursday that three other states can move ahead with their effort to roll back federal rules and make it harder for people across the U.S. to access the abortion drug ...
Several states, including Massachusetts, began stockpiling the drug after a federal court ruling in Texas blocked the FDA’s ...
An increased public interest and support for medication abortion following the federal Supreme Court ruling, particularly ...
Anxiety around access to contraceptive healthcare is at an all-time high, writes Kirsten Meisinger, a family doctor. The reality is that the political climate will not improve soon. But contrary to ...